Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 6Motor Activity 3Sleep Wake Disorders 2Overweight 2Ovarian Neoplasms 2Obesity 2Colorectal Neoplasms 2Colonic Neoplasms 2Weight Loss 1Urinary Bladder Neoplasms 1Thyroid Cancer, Papillary 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Kidney Neoplasms 1Intermittent Fasting 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Feeding Behavior 1Fatigue 1Fasting 1Endometrial Neoplasms 1Depressive Disorder 1Depression 1Castration-Resistant Prostate Cancer (CRPC) 1

Interventions

pembrolizumab 36Bevacizumab 25Cyclophosphamide 23Blood Specimen Collection 19Nivolumab 17Standard of Care 15Carboplatin 15Paclitaxel 14atezolizumab 13Gemcitabine 13Exercise 13Pemetrexed 11Fluorouracil 11Doxorubicin 11Cisplatin 11Cetuximab 10Radiotherapy 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Docetaxel 9130-nm albumin-bound paclitaxel 9durvalumab 8abemaciclib 8Temozolomide 8Surveys and Questionnaires 8Rituximab 8Prednisone 8Biopsy 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Counseling × 90 days × Clear all
NCT06184256 2026-05-18

BfedBwell Optimization Pilot

University of Colorado, Denver

Phase NA Active not recruiting
73 enrolled
Other

Motor Activity, Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡